Johanna Olweus awarded King Olav V's Prize for Cancer Research for 2026
King Olav V's Cancer Research Prize has been awarded every year since 1992 by the Norwegian Cancer Socitey to a cancer researcher or a research group that has contributed to promoting the quality and scope of Norwegian cancer research. The prize, amounting to 1 million NOK, has high prestige in the Norwegian research community and goes to the very best researchers within the entire spectrum of Norwegian cancer research.
For 2026, the award went to Johanna Olweus, leader of the the Experimental Immunotherapy Group at the Institute for Cancer Research. H.M. King Harald presented the prize during a ceremony in The Aula of the University of Oslo on May 19th.
Links:
News articles (in Norwegian):
Feature article from the Norwegian Cancer Society:
– Jeg er nok litt besatt (kreftforeningen.no)
The Royal House of Norway:
Prestisjetung kreftforskningspris (kongehuset.no)
Uniforum, a newspaper published by the University of Oslo:
Kong Olav Vs kreftforskningspris til UiO-professor (uniforum.no)
The Norwegian Broadcasting Corporation:
Oliver blei kreftfri på ti dagar – forskar som vidareutviklar behandlinga får gjæv pris (nrk.no)
The Experimental Immunotherapy Group, headed by Johanna Olweus